Article
Resistance to thyroid hormone is modulated in vivo by the nuclear receptor corepressor (NCOR1).
Proceedings of the National Academy of Sciences of the United States of America - 18 Oct 2011
Fozzatti Laura, Lu Changxue, Kim Dong Wook, Park Jeong Won, Astapova Inna, Gavrilova Oksana, Willingham Mark C, Hollenberg Anthony N, Cheng Sheue-yann
Abstract excerpt
Mutations in the ligand-binding domain of the thyroid hormone receptor β (TRβ) lead to resistance to thyroid hormone (RTH). These TRβ mutants function in a dominant-negative fashion to interfere with the transcription activity of wild-type thyroid hormone receptors (TRs), leading to dysregulation of the pituitary-thyroid axis and resistance in peripheral tissues. The molecular mechanism by which TRβ mutants cause...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
